ResearcherSeoul National UniversityNo recent work listed
Younak Choi
Matched on OpenAlex author ID A5102257279. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2014: 1 paper · 2015: 1 paper · 2016: 3 papers · 2017: none · 2018: none · 2019: 1 paper
Papers 6
- Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korea… Co-author DOI 10.1177/1758835919871126↗
- More Accurate Prediction of Metastatic Pancreatic Cancer Patients' Survival with Prognostic Model Using Both Host Immunity and Tumor Metabolic Activity. Co-author DOI 10.1371/journal.pone.0145692↗
- The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy. Co-author DOI 10.4143/crt.2014.292↗
- Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study. Co-author DOI 10.4143/crt.2015.226↗
- Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index. Co-author DOI 10.1371/journal.pone.0139749↗
- The impact of body mass index dynamics on survival of patients with advanced pancreatic cancer receiving chemotherapy. Co-author DOI 10.1016/j.jpainsymman.2013.08.017↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Do‐Youn Oh · 6 shared papers, 2014–2019 · strength 0.35
- Paper Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancrea… DOI 10.1177/1758835919871126↗
- Paper The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergo… DOI 10.4143/crt.2014.292↗
- Paper More Accurate Prediction of Metastatic Pancreatic Cancer Patients' Survival with Prognostic Model Using Both Host Immun… DOI 10.1371/journal.pone.0145692↗
- Kyung-Hun Lee · 5 shared papers, 2015–2019 · strength 0.31
- Paper Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancrea… DOI 10.1177/1758835919871126↗
- Paper The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergo… DOI 10.4143/crt.2014.292↗
- Paper More Accurate Prediction of Metastatic Pancreatic Cancer Patients' Survival with Prognostic Model Using Both Host Immun… DOI 10.1371/journal.pone.0145692↗
- Seock‐Ah Im · 5 shared papers, 2014–2016 · strength 0.27
- Paper The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergo… DOI 10.4143/crt.2014.292↗
- Paper More Accurate Prediction of Metastatic Pancreatic Cancer Patients' Survival with Prognostic Model Using Both Host Immun… DOI 10.1371/journal.pone.0145692↗
- Paper Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospec… DOI 10.4143/crt.2015.226↗
- Yung‐Jue Bang · 5 shared papers, 2014–2016 · strength 0.27
- Paper The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergo… DOI 10.4143/crt.2014.292↗
- Paper More Accurate Prediction of Metastatic Pancreatic Cancer Patients' Survival with Prognostic Model Using Both Host Immun… DOI 10.1371/journal.pone.0145692↗
- Paper Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospec… DOI 10.4143/crt.2015.226↗
- Hye Jin Choi · 1 shared paper, 2019 · strength 0.08
- Seung Tae Kim · 1 shared paper, 2019 · strength 0.08
- Kyu‐pyo Kim · 1 shared paper, 2019 · strength 0.08
- Baek‐Yeol Ryoo · 1 shared paper, 2019 · strength 0.08
- Joon Oh Park · 1 shared paper, 2019 · strength 0.08
- Changhoon Yoo · 1 shared paper, 2019 · strength 0.08
- Hyunkyung Park · 1 shared paper, 2016 · strength 0.06
- Kyubo Kim · 1 shared paper, 2016 · strength 0.05
- Sung Whan Ha · 1 shared paper, 2016 · strength 0.05
- Eui Kyu Chie · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.